ConductScience.org, home

Library / Trial comparisons

Adults on CSII Treatment vs Paediatric Patients on CSII Treatment: Number of Patients With HbA1c on Target Using Advanced Pump's Functions, CGM and CHO Counting

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

Measures 6

Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.

MeasureValue95% interval, lower95% interval, upperMethodNoteSource
Risk in group 10.3060.2940.318wilsonClinicalTrials.gov
Risk in group 20.5020.4720.533wilsonClinicalTrials.gov
Risk difference, group 1 minus group 2-0.196-0.229-0.164newcombe hybrid scoreClinicalTrials.gov
Risk ratio, group 1 over group 20.6090.5660.655logClinicalTrials.gov
Odds ratio, group 1 over group 20.4370.3820.5logClinicalTrials.gov
Number needed to treat, for one fewer participant with the outcome on Adults on CSII Treatment than on Paediatric Patients on CSII Treatment5.094.366.12from the risk difference intervalClinicalTrials.gov

Groups 2

Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.

GroupTitleDescriptionWith the outcomeAnalysedClinicalTrials.gov codeSource
Group 1Adults on CSII TreatmentPatients who received CSII treatment in Italy ( = or \> 18 YEARS OLD)1,7135,598OG000ClinicalTrials.gov
Group 2Paediatric Patients on CSII TreatmentPatients \< 18 years old ON CSII treatment5151,025OG001ClinicalTrials.gov

Outcome 5

FieldValueSource
TypeSECONDARYClinicalTrials.gov
TitleNumber of Patients With HbA1c on Target Using Advanced Pump's Functions, CGM and CHO CountingClinicalTrials.gov
Description
number of patients adults with HbA1c \<7,0% using advanced pump's functions, CGM and CHO counting number of paediatrics patients with HbA1c \< 7.5% using advanced pump's functions, CGM and CHO counting
ClinicalTrials.gov
Time frame1 yearClinicalTrials.gov
PopulationClinicalTrials.gov

Trial 8

FieldValueSource
TitleContinuos Subcutaneous Insulin Infusion in ItalyClinicalTrials.gov
NCT numberNCT02620917ClinicalTrials.gov
PhasesClinicalTrials.gov
ConditionsType 1 DiabetesClinicalTrials.gov
InterventionsClinicalTrials.gov
Lead sponsorUniversity of PadovaClinicalTrials.gov
Results first posted2020-04-08ClinicalTrials.gov
Results on ClinicalTrials.govhttps://clinicaltrials.gov/study/NCT02620917?tab=resultsClinicalTrials.gov

Source 4

FieldValueSource
Releasetrial-comparisons-2026-03-23-0.1.0ClinicalTrials.gov
Release manifest SHA-256f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57ClinicalTrials.gov
AACT copy2026-03-23ClinicalTrials.gov
Tables readoutcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquetClinicalTrials.gov

The same record as JSON

Release trial-comparisons-2026-03-23-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.